Skip to the answer

Galantamine

Galantamine is a cholinesterase inhibitor used to treat mild to moderate dementia of the Alzheimer’s type, available as extended-release capsules, tablets and oral solution.

Brand names Razadyne ERGalantamine Hydrobromide
Drug class Cholinesterase Inhibitors
Rx Forms 3
Dr. Brian Staiger, PharmD, BCPS
Reviewed by Last reviewed Jul 10, 2026 Content updated Oct 2, 2026
🧬 Where this information comes from Click to expand

The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 17 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →

✓No current FDA shortage listed · checked Oct 7, 2026
Galantamine at a glance The quick version — the full detail is in the Patient Information Guide below.
Dr. Brian Staiger, PharmD, BCPS
The Pharmacist’s Take By · Clinical pharmacist · Written

Galantamine is a cholinesterase inhibitor for mild to moderate dementia of the Alzheimer’s type, blocking the enzyme that breaks down acetylcholine (a brain messenger for memory and thinking). It is a familiar alternative to donepezil, on the market since about 2001 and available generically. Most people manage it once the dose climbs slowly, but nausea is common early, along with vomiting, diarrhea or a smaller appetite. Watch for a heartbeat that slows too much, which shows up as fainting or a very slow pulse, and stop it and call the prescriber at the first skin rash. It eases symptoms but does not change the course of the disease.

Clinical pearls

  • Take it with food, in the morning for the extended-release capsule, and drink plenty of fluids during treatment.
  • After more than three missed days in a row, do not restart the old dose; the prescriber restarts it low.
  • Tell surgeons and anesthesia staff you take it, because it can exaggerate succinylcholine-type muscle relaxants given during surgery.
  • Ibuprofen and similar NSAIDs raise ulcer risk on galantamine, so report black or bloody stools or vomiting blood promptly.
How you get itPrescription only
Comes asTablet, Extended-release capsule, Oral solution
Earliest FDA record2001
Companies listing it with the FDA9
FDA label last updatedJan 30, 2024
FDA’s strongest warning (boxed)None on the label

Patient information guide A plain-language walkthrough of Galantamine, written from its FDA label.

What Galantamine is used for

▾

Galantamine is used for one condition across all the products covered here.

  • Mild to moderate dementia of the Alzheimer’s type (extended-release capsules, tablets and oral solution)

How Galantamine works

▾

Acetylcholine-producing brain cells degenerate in Alzheimer’s disease, and this loss is linked to memory and thinking problems. Galantamine reversibly blocks acetylcholinesterase, the enzyme that breaks acetylcholine down. That raises acetylcholine levels and is thought to improve nerve signaling.

Its effect may lessen as the disease advances. There is no evidence it alters the underlying disease process.

Galantamine dosage

▾

Galantamine is taken by mouth. Dosing starts low and rises slowly, with at least 4 weeks between increases, based on benefit and tolerability.

  • Extended-release capsules: once daily in the morning, preferably with food.
  • Tablets and oral solution: twice daily, preferably with morning and evening meals.
  • Drink enough fluids during treatment.
  • If you stop for more than three days, your prescriber will restart you at the lowest dose.

Follow your prescriber’s directions and the label.

Dosing details from the FDA-approved label

From the Galantamine prescribing information (“Dosage and Administration”). Doses are set by your prescriber for your product, condition, kidney function and age — never change a dose on your own.

  • Galantamine extended-release capsules (general dosing)
    • Starting dosage 8 mg/day in the morning
    • Increase to the initial maintenance dose of 16 mg/day after a minimum of 4 weeks
    • May be increased to 24 mg/day after a minimum of 4 weeks at 16 mg/day, based on clinical benefit and tolerability
    • The dosage shown to be effective in a controlled clinical trial is 16 to 24 mg/day
    • Maximum: 24 mg/day
    • Administer once daily in the morning, preferably with food; ensure adequate fluid intake
  • Galantamine oral solution (general dosing)
    • Starting dosage 4 mg (1 mL) twice daily
    • Increase to the initial maintenance dosage of 8 mg (2 mL) twice daily after a minimum of 4 weeks
    • May be increased to 12 mg (3 mL) twice daily after a minimum of 4 weeks at 8 mg (2 mL) twice daily
    • Recommended dosage range is 16 mg to 24 mg/day given twice daily
    • Maximum: 24 mg (6 mL)/day
    • Take twice a day, preferably with morning and evening meals; ensure adequate fluid intake
  • Moderate hepatic impairment (Child-Pugh score of 7 to 9)
    • Dosage should generally not exceed 16 mg/day (oral solution: 16 mg (4 mL)/day)
    • Maximum: 16 mg/day
    • Use not recommended in severe hepatic impairment (Child-Pugh score of 10 to 15)
  • Renal impairment, creatinine clearance 9 to 59 mL/min
    • Dosage should generally not exceed 16 mg/day (oral solution: 16 mg (4 mL)/day)
    • Maximum: 16 mg/day
    • Use not recommended if creatinine clearance is less than 9 mL/min
  • Conversion from galantamine tablets to extended-release capsules
    • Take the last dose of tablets in the evening and start extended-release capsules once daily the next morning, at the same total daily dosage
  • Therapy interrupted for more than three days
    • Restart at the lowest dosage and escalate to the current dose
Read the label’s full dosing text

2 DOSAGE AND ADMINISTRATION Recommended starting dosage is 8 mg/day in morning; increase to initial maintenance dose of 16 mg/day after a minimum of 4 weeks. Based on clinical benefit and tolerability, dosage may be increased to 24 mg/day after a minimum of 4 weeks at 16 mg/day. ( 2.1 ) Take with food; ensure adequate fluid intake during treatment (2.1) Hepatic impairment: should not exceed 16 mg/day for moderate hepatic impairment; do not use in patients with severe hepatic impairment ( 2.2 ) Renal impairment: should not exceed 16 mg/day for creatinine clearance 9 to 59 mL/min; do not use in patients with creatinine clearance less than 9 mL/min. ( 2.3 ) Conversion from galantamine tablets to galantamine extended-release capsules should occur at the same daily dosage with the last dose of galantamine tablets taken in evening and starting galantamine extended-release capsules once daily treatment the next morning. ( 2.5 ) 2.1 Recommended Dosage and Administration Administer galantamine extended-release capsules once daily in the morning, preferably with food. Ensure adequate fluid intake during treatment. The recommended starting dosage of galantamine extended-release capsules is 8 mg/day. Increase to the initial maintenance dosage of 16 mg/day after a minimum of 4 weeks. A further increase to 24 mg/day may be attempted after a minimum of 4 weeks at 16 mg/day. Increase dosage based upon assessment of clinical benefit and tolerability of the previous dosage. The dosage of galantamine extended-release capsules shown to be effective in a controlled clinical trial is 16 to 24 mg/day. 2.2 Dosage in Patients with Hepatic Impairment In patients with moderate hepatic impairment (Child-Pugh score of 7 to 9), the dosage should generally not exceed 16 mg/day. The use of galantamine extended-release capsules in patients with severe hepatic impairment (Child-Pugh score of 10 to 15) is not recommended [see Clinical Pharmacology (12.3) ] . 2.3 Dosage in Patients with Renal Impairment In patients with creatinine clearance of 9 to 59 mL/min, the dosage should generally not exceed 16 mg/day. In patients with creatinine clearance less than 9 mL/min, the use of galantamine extended-release capsules is not recommended [see Clinical Pharmacology (12.3) ] .

Excerpted — the section continues on the label. Read the full Dosage and Administration section on DailyMed →

Galantamine side effects

▾

Most side effects are stomach-related and happen mainly while the dose is being raised.

Common side effects

  • Nausea (the most common)
  • Vomiting
  • Diarrhea
  • Dizziness
  • Headache
  • Decreased appetite
  • Weight loss
  • Fatigue

When to get medical help

  • Stop the medicine and call your doctor at the first sign of a skin rash. Serious skin reactions (Stevens-Johnson syndrome and acute generalized exanthematous pustulosis) have been reported.
  • Get help for a very slow heartbeat, fainting or signs of heart block.
  • Call your doctor for black or bloody stools, vomiting blood or stomach pain, which may signal stomach or intestinal bleeding.
  • Report seizures right away.
  • Report trouble passing urine.
  • Report new or worse breathing problems, especially if you have asthma or lung disease.
  • Get emergency help for suspected overdose: severe nausea and vomiting, drooling, sweating, slow heartbeat, muscle weakness, trouble breathing or collapse.

Galantamine warnings and precautions

▾
  • Serious skin reactions: stop at the first rash unless clearly not drug-related.
  • Heart rhythm: can cause a slow heartbeat and heart block; fainting risk rises with dose.
  • Stomach and weight: watch for bleeding, especially with ulcer history or NSAID use; weight should be monitored.
  • Seizures: monitor closely.
  • Bladder and lungs: may cause bladder outflow obstruction; use care with severe asthma or lung disease.
  • Anesthesia: may exaggerate the effects of succinylcholine-type muscle relaxants.
  • Mild cognitive impairment: in two studies, more deaths occurred with galantamine than placebo.

Galantamine interactions

▾

Galantamine can clash with several medicine types.

  • Anticholinergic medicines: galantamine may interfere with their activity.
  • Other cholinesterase inhibitors: effects add together.
  • Cholinergic agonists such as bethanechol: effects add together.
  • Succinylcholine and similar muscle relaxants: effects may be exaggerated.
  • NSAIDs: raise ulcer risk, so watch for bleeding.

Interactions listed in the FDA-approved label

From the Galantamine prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.

  • Anticholinergic medications: Galantamine has the potential to interfere with the activity of anticholinergic medications.
  • Succinylcholine, similar neuromuscular blocking agents: A synergistic effect is expected when given concurrently with cholinesterase inhibitors.
  • Other cholinesterase inhibitors: A synergistic effect is expected when cholinesterase inhibitors are given concurrently.
  • Cholinergic agonists such as bethanechol: A synergistic effect is expected when given concurrently with cholinesterase inhibitors.
Read the label’s full interactions text

7 DRUG INTERACTIONS • Potential to interfere with the activity of anticholinergic medications. ( 7.1 ) • Synergistic effect expected when given concurrently with succinylcholine, other cholinesterase inhibitors, similar neuromuscular blocking agents, or cholinergic agonists. ( 7.2 ) 7.1 Use with Anticholinergics Galantamine has the potential to interfere with the activity of anticholinergic medications [see Clinical Pharmacology (12.3) ] . 7.2 Use with Cholinomimetics and Other Cholinesterase Inhibitors A synergistic effect is expected when cholinesterase inhibitors are given concurrently with succinylcholine, other cholinesterase inhibitors, similar neuromuscular blocking agents or cholinergic agonists such as bethanechol [see Clinical Pharmacology (12.3) ] .

Read the full Drug Interactions section on DailyMed →

Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.

Before taking Galantamine

▾
  • Do not use if allergic to galantamine hydrobromide or any ingredient.
  • Moderate liver impairment or kidney impairment (creatinine clearance 9 to 59 mL/min): the dose should generally be limited.
  • Severe liver impairment or creatinine clearance below 9 mL/min: not recommended.
  • Pregnancy: no adequate human data; animal studies showed developmental harm.
  • Breastfeeding: no data; weigh benefits and risks with your doctor.
  • Children: safety and effectiveness not established.
  • Older adults: studied mostly in people with an average age of 75.

Galantamine overdose

▾

Too much galantamine can cause cholinergic crisis: severe nausea, vomiting, cramping, drooling, sweating, slow heartbeat, low blood pressure, muscle weakness, breathing trouble, collapse and convulsions. Call a poison control center or get emergency care. Atropine may be used as an antidote in the hospital.

What Galantamine does in the body

▾

Galantamine raises acetylcholine levels by reversibly inhibiting cholinesterase. This is thought to enhance cholinergic function. About 7% of people are CYP2D6 poor metabolizers, who clear galantamine somewhat more slowly. No dose change is needed for them because dosing is adjusted to tolerability.

How your body processes Galantamine

▾

Galantamine is well absorbed (about 90% bioavailability) and peaks in about 1 hour as tablets or solution. Extended-release capsules peak later, around 4.5 to 5 hours. It is processed by liver enzymes (CYP2D6 and CYP3A4) and cleared mostly in urine. Its half-life is about 7 hours.

Levels are higher in people with moderate liver impairment or kidney impairment, and in women, who tend to weigh less.

How to store Galantamine

▾

stored at 25°C (77°F); excursions permitted between 15°C to 30°C (59°F to 86°F) . Keep out of reach of children.

Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI →

170

Supplements & herbs that interact with Galantamine

170 supplements and herbal products have documented interactions with Galantamine in the licensed clinical database we use. Most are manageable — but your pharmacist should know about everything you take, including vitamins and herbals.

Severity mix
  • Major · 3
  • Moderate · 126
  • Minor · 41
Every supplement checked against Galantamine — ranked by severity The full interaction hub: 3 major · 126 moderate · 41 minor · every one linked to its full report. Check Galantamine against your exact supplements

Educational information from a licensed clinical database (Natural Medicines) — see our data sources & update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.

Galantamine: pharmacist answers to common questions

Quick, plain-English answers to the questions patients ask most about Galantamine — the kind of thing our pharmacy team would talk through with you at the counter.

What is galantamine for?

▾
It treats mild to moderate dementia of the Alzheimer’s type. It helps manage symptoms by boosting a brain chemical involved in memory and thinking. It does not stop the disease from progressing.

How should I take it?

▾
The extended-release capsule is taken once a day in the morning, preferably with food. The tablets and oral solution are taken twice a day with morning and evening meals. Drink plenty of fluids. If you miss more than three days, call your prescriber, because you will need to restart at the lowest dose.

What side effects should I expect?

▾
Nausea is the most common, along with vomiting, diarrhea, dizziness, headache and less appetite. These mostly show up while the dose is going up. Nausea usually lasts about a week or less in those who get it.

When should I call my doctor?

▾
Stop the medicine and call right away if you get a skin rash. Also call for fainting, a very slow heartbeat, seizures, black or bloody stools, or trouble urinating or breathing.

Can I take it with my other medicines?

▾
Tell me about everything you take. Galantamine can clash with anticholinergic medicines and add to the effects of other cholinesterase inhibitors. Be careful with NSAIDs, which raise ulcer risk. Tell any surgeon or anesthesia team you take it.

Is it safe in pregnancy?

▾
There are no adequate human data. Animal studies showed harm to offspring at doses similar to or higher than those used in people. Talk with your doctor if you are pregnant or planning to be.

Is Galantamine available over the counter?

▾
No. Galantamine is a prescription medicine: every Galantamine product listed with the FDA is prescription only, so it is not sold over the counter. Your prescriber decides whether it is appropriate for you, and your pharmacist dispenses it.

When was Galantamine first available?

▾
The earliest FDA record we hold for Galantamine is from 2001: its first approval in Drugs@FDA or its earliest product listing in the NDC Directory, whichever is older. Many older medicines were in use before their first formal FDA approval, so this is the earliest date on record, not necessarily when Galantamine was first used.

Who makes Galantamine?

▾
9 companies currently list Galantamine products in the FDA's NDC Directory, including Bryant Ranch Prepack, Aurobindo Pharma Limited, Golden State Medical Supply, Inc.. That count includes repackagers and distributors as well as manufacturers (companies that sell only the raw ingredient are not counted), so fewer companies actually make it; the label on your bottle names the one that supplied yours.

Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI →

More about Galantamine on HelloPharmacist

Detailed data & references for Galantamine Forms & strengths, pricing, billing codes, manufacturers, safety reports and sourcing — the data behind the page. Most people can stop here. Each section below opens on a tap.

Galantamine forms and strengths (how it comes)

Galantamine is available in 3 forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.

Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Galantamine inactive ingredients by manufacturer.

Tablet

By mouth
How this form is used
What it may be used for
  • Galantamine tablets are used for mild to moderate dementia of the Alzheimer’s type.
Important instructions
  • Galantamine tablets are taken twice a day, preferably with morning and evening meals.
  • Galantamine tablets: the dose is raised gradually, no sooner than every 4 weeks.
  • Galantamine tablets: if therapy is interrupted for more than three days, restart at the lowest dosage.
Available strengths 3 strengths
38 FDA-listed product records ⓘ

Extended-release capsule

By mouth
Brands Galantamine Hydrobromide
How this form is used
What it may be used for
  • Galantamine extended-release capsules are used for mild to moderate dementia of the Alzheimer’s type.
  • Galantamine Hydrobromide extended-release capsules are used for mild to moderate dementia of the Alzheimer’s type.
Important instructions
  • Galantamine extended-release capsules are taken once daily in the morning, preferably with food.
  • Galantamine extended-release capsules: if switching from galantamine tablets, take the last tablet dose in the evening and start the capsule the next morning at the same total daily dosage.
  • Galantamine extended-release capsules: drink enough fluids during treatment.
Available strengths 3 strengths
27 FDA-listed product records ⓘ

Oral solution

By mouth
Brands Galantamine Hydrobromide
How this form is used
What it may be used for
  • Galantamine Hydrobromide oral solution is used for mild to moderate dementia of the Alzheimer’s type.
Important instructions
  • Galantamine Hydrobromide oral solution is taken twice a day, preferably with morning and evening meals.
  • Galantamine Hydrobromide oral solution: the dose is raised gradually, no sooner than every 4 weeks.
  • Galantamine Hydrobromide oral solution: drink enough fluids during treatment.
Available strengths 1 strength
2 FDA-listed product records ⓘ

Galantamine on the U.S. market: products, makers and brands

How Galantamine appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.

9 companies list 31 Galantamine product records with the FDA, mostly as tablet, extended-release capsule, oral solution; the earliest marketing or approval year on record is 2001. Brand names on the directory include Razadyne ER, Galantamine Hydrobromide; the rest are generics.

3
Dose forms ⓘ
9
Labelers (makers, repackagers, distributors)
2
Brand names
31
FDA-listed product records ⓘ
2001
Earliest FDA record ⓘ

FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

Also listed with the FDA, not a patient dose form: Powder (7) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.

Bryant Ranch Prepack26%
Aurobindo Pharma Limited19%
Golden State Medical Supply, Inc.10%
Rising Pharma Holdings, Inc.10%
Slate Run Pharmaceuticals, LLC10%
Sun Pharmaceutical Industries, Inc.10%
Other makers16%

Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

How widely Galantamine is used (Medicaid data)

A general measure of how commonly Galantamine is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.

Think of this as a proxy for how widely Galantamine is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.

4,431
Medicaid prescriptions filled (Q1–Q4 2025)
$134,395 gross Medicaid reimbursement (before mandatory rebates — net cost is lower)

How commonly is Galantamine prescribed? Of the 1,601 medications we measure, Galantamine ranks #1,066 by Medicaid prescriptions — more than 33% of them.

Where Galantamine ranks among the drugs we measure · Q1–Q4 2025 · neighbors ±5

Utilization by Galantamine product

Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.

The 4 mg oral tablet is the most-dispensed Galantamine product — about 48% of these Medicaid prescriptions.

galantamine 4 MG Oral Tablet Most dispensed

2,106 Medicaid prescriptions (Q1–Q4 2025) 48% of Galantamine prescriptions shown $51,181 gross reimbursement (before rebates) ≈ $24 per prescription (gross)

Summed across the 3 of 29 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 310436

galantamine 8 MG Oral Tablet

1,569 Medicaid prescriptions (Q1–Q4 2025) 35% of Galantamine prescriptions shown $44,554 gross reimbursement (before rebates) ≈ $28 per prescription (gross)

Summed across the 3 of 24 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 310437

24 HR galantamine hydrobromide 8 MG Extended Release Oral Capsule

516 Medicaid prescriptions (Q1–Q4 2025) 12% of Galantamine prescriptions shown $25,849 gross reimbursement (before rebates) ≈ $50 per prescription (gross)

Summed across the 2 of 14 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 860715

galantamine 12 MG Oral Tablet

112 Medicaid prescriptions (Q1–Q4 2025) 3% of Galantamine prescriptions shown $6,556 gross reimbursement (before rebates) ≈ $59 per prescription (gross)

Summed across the 3 of 23 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 579148

24 HR galantamine hydrobromide 16 MG Extended Release Oral Capsule

98 Medicaid prescriptions (Q1–Q4 2025) 2% of Galantamine prescriptions shown $4,813 gross reimbursement (before rebates) ≈ $49 per prescription (gross)

Summed across the 1 of 16 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 860695

24 HR galantamine hydrobromide 24 MG Extended Release Oral Capsule

30 Medicaid prescriptions (Q1–Q4 2025) <1% of Galantamine prescriptions shown $1,441 gross reimbursement (before rebates) ≈ $48 per prescription (gross)

Summed across the 1 of 14 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 860707

Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.

Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Galantamine, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 13 of 120 listed Galantamine NDCs with Medicaid activity.

Compare Galantamine products

A representative set of FDA-listed product records for Galantamine — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)

Showing 31 of 31 products — FDA National Drug Code Directory. See every product, package size and price: browse all 31 Galantamine NDCs →

Galantamine recall history

A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.

The FDA’s enforcement reports list no Galantamine recalls since July 2021.

✅No Galantamine recalls on record since July 2021

Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Sep 24, 2026.

RxNorm Concept Web — From Ingredient to Every Form and Strength

This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.

Ingredient (IN) Galantamine RxCUI 4637 3 dose forms · 7 strengths
  1. Dose form (SCDF) Oral Solution RxCUI 384642 In current FDA listings
    Clinical drug / strength (SCD) hydrobromide 4 MG/ML RxCUI 860901
  2. Dose form (SCDF) Oral Tablet RxCUI 384641 In current FDA listings
    Clinical drug / strength (SCD) 4 MG RxCUI 310436 8 MG RxCUI 310437 12 MG RxCUI 579148

Look up RxCUI 4637 in the RxCUI Atlas →

RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.

💵 What Galantamine costs pharmacies (NADAC benchmark)

The national average invoice price pharmacies pay for the drug itself, from CMS's NADAC survey (data as of Sep 30, 2026). This is a supply-cost benchmark — not a retail price and not what you'd pay at the counter.

FormStrengthPharmacy acquisition benchmark
Tablet, Film Coated · Oral 4 mg $0.294 per tablet NDC details & price history
Tablet, Film Coated · Oral 8 mg $0.402 per tablet NDC details & price history
Tablet, Film Coated · Oral 12 mg $0.513 per tablet NDC details & price history
Capsule, Extended Release · Oral 8 mg $0.802 per capsule NDC details & price history
Capsule, Extended Release · Oral 16 mg $0.846 per capsule NDC details & price history
Capsule, Extended Release · Oral 24 mg $0.905 per capsule NDC details & price history
Tablet, Film Coated 8 mg $0.402 per tablet NDC details & price history
Tablet, Film Coated 12 mg $0.513 per tablet NDC details & price history
Tablet, Film Coated 4 mg $0.294 per tablet NDC details & price history
Why show this? Your out-of-pocket cost depends on insurance, pharmacy markup, and discounts — but the acquisition benchmark tells you whether the medication itself is inexpensive or costly, which strengths cost more per dose, and whether a cash-price quote is in a reasonable range. Each row links to the NDC-level record with its full price history.

Source: CMS National Average Drug Acquisition Cost (NADAC), a survey of retail pharmacy invoice prices. Benchmarks shown are the range across package sizes of a representative product for each form and strength — other manufacturers' products may differ.

Galantamine brand names

Galantamine is sold under 2 brand names in the FDA directory — Razadyne ER, Galantamine Hydrobromide. A brand and its generic contain the same active ingredient; the brand name belongs to one company's product.

Razadyne ER Galantamine Hydrobromide

Who makes Galantamine: manufacturers and labelers

9 companies list Galantamine products with the FDA. By number of product records, the largest are Bryant Ranch Prepack, Aurobindo Pharma Limited, Golden State Medical Supply, Inc.. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.

Bryant Ranch Prepack 8 Aurobindo Pharma Limited 6 Golden State Medical Supply, Inc. 3 Rising Pharma Holdings, Inc. 3 Slate Run Pharmaceuticals, LLC 3 Sun Pharmaceutical Industries, Inc. 3 Upsher-Smith Laboratories, LLC 3 American Health Packaging 1 Hikma Pharmaceuticals USA Inc. 1

Galantamine drug class (RxNorm)

Galantamine belongs to the Cholinesterase Inhibitor class.

Pharmacologic class Cholinesterase Inhibitor
Drug family (ATC) Anticholinesterases
How it works Cholinesterase Inhibitors

Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.

Sources for this Galantamine page

Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.

📄
FDA-filed drug labels (SPL) Uses, dosing, warnings & side effects from SPL records retrieved through openFDA; the linked representative set can be verified on DailyMed. ✓ Linked label effective Jan 30, 2024
🏭
Forms, brands & labelersAggregated from ingredient-matched FDA National Drug Code Directory product records for Galantamine.
📈
Real-world reportsThe FDA Adverse Event Reporting System (FAERS), served through openFDA.
🚨
Recalls & shortagesopenFDA drug-enforcement reports and the FDA drug-shortage database.
🧾 Clinical label set — FDA-filed SPL labels retained for Galantamine after exact ingredient or ingredient-combination matching and applicable route/form matching
Clinical labels in scope
17
Finished products in the current FDA directory
31
Companies listing them (makers, repackagers, distributors)
9
FDA labeler codes behind them ⓘ
11
Linked representative label ⓘ
Aurobindo Pharma Limited
Linked label effective
Jan 30, 2024
Composite sections available
23
Linked SPL Set ID
d0b75970-8d3d-408b-9e17-9cbad0f776b1
Linked SPL Document ID
5b352114-093a-450c-81d1-4914dac5e2e3
Open the linked representative label on DailyMed ↗

How this page is built

HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Aurobindo Pharma Limited is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →